Cite
HARVARD Citation
Saxena, S. et al. (2022). Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane®): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects. Pharmacology research & perspectives. 10 (4), p. n/a. [Online].